Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07580833
What this trial is testing

Investigate the Effect of Food on the Bioavailability of Oral Paclitaxel Administered With Encequidar in Participants With Advanced Solid Tumors

Who this might be right for
Metastatic Breast Cancer
Health Hope Pharma 46
Testing effectiveness (Phase 2)Ended earlyNCT00420732
What this trial is testing

Vaccine Maintenance Treatment for Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
NewLink Genetics Corporation 6
Testing effectiveness (Phase 2)Ended earlyNCT00683787
What this trial is testing

Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Gastric Cancer
Roswell Park Cancer Institute 8
Testing effectiveness (Phase 2)Ended earlyNCT00004093
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Northwestern University 36
Testing effectiveness (Phase 2)Study completedNCT00533533
What this trial is testing

A Phase I/II Trial of Docetaxel and Oxaliplatin in Patients With Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Samsung Medical Center 68
Not applicableStudy completedNCT04394247
What this trial is testing

Patient Characteristics, Treatment Patterns, and Clinical Outcomes in Patients Diagnosed With HR+/HER2 Advanced/Metastatic Breast Cancer on Palbociclib + Aromatase Inhibitor (AI) Combination Therapy

Who this might be right for
Breast Cancer
Pfizer 242
Early research (Phase 1)Looking for participantsNCT06551584
What this trial is testing

Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoid LeukemiaMixed Phenotype Acute Leukemia+1 more
Stanford University 24
Testing effectiveness (Phase 2)Study completedNCT04507906
What this trial is testing

Nivolumab Combined With Anlotinib as Re-challenge Treatment in Advanced NSCLC

Who this might be right for
NSCLC Stage IVCheckpoint Inhibitor
Shanghai Chest Hospital 21
Testing effectiveness (Phase 2)UnknownNCT05865132
What this trial is testing

Palbociclib Combined With Afatinib for Advanced Squamous Carcinoma of Esophagus or Gastroesophageal Junction

Who this might be right for
Esophagus Squamous Cell Carcinoma
AIPING ZHOU 30
Large-scale testing (Phase 3)UnknownNCT04222114
What this trial is testing

Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis

Who this might be right for
Stomach Neoplasms
LintonPharm Co.,Ltd. 282
Testing effectiveness (Phase 2)Study completedNCT06226350
What this trial is testing

A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma

Who this might be right for
Cervical Cancer
Shandong New Time Pharmaceutical Co., LTD 29
Early research (Phase 1)Study completedNCT00098891
What this trial is testing

MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas

Who this might be right for
Adult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+41 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Looking for participantsNCT07085091
What this trial is testing

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)HNSCCCRC (Colorectal Cancer)+4 more
ALX Oncology Inc. 170
Not applicableStudy completedNCT00124410
What this trial is testing

Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation

Who this might be right for
Prostate CancerOsteoporosis
AHS Cancer Control Alberta 100
Testing effectiveness (Phase 2)Looking for participantsNCT07500220
What this trial is testing

Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)Metastatic Liver Cancer
Beijing Biotech 30
Testing effectiveness (Phase 2)Study completedNCT00004924
What this trial is testing

Paclitaxel and Irinotecan in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Yale University 28
Not applicableStudy completedNCT05207423
What this trial is testing

A Chart Review Study of Adults With Advanced NSCLC

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Takeda 179
Testing effectiveness (Phase 2)Ended earlyNCT04515979
What this trial is testing

Vactosertib in Combination with Pembrolizumab for PD-L1 Positive Non-small Cell Lung Cancer (NSCLC) Subjects

Who this might be right for
Carcinoma, Non-Small-Cell Lung
MedPacto, Inc. 11
Testing effectiveness (Phase 2)Active Not RecruitingNCT05688280
What this trial is testing

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

Who this might be right for
Metastatic Solid TumorColon CancerNonsmall Cell Lung Cancer+1 more
Immunophotonics, Inc. 42
Large-scale testing (Phase 3)Ended earlyNCT01379976
What this trial is testing

Acetyl-L-carnitine in Combination With a Cisplatin-containing Chemotherapy as First Line Treatment of Advanced or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Mario Negri Institute for Pharmacological Research 107
Next Page